US EditionPandemic disruptions to health care worsened cancer survival, study suggests
More than 1 million cancer patients diagnosed in 2020–21 had lower one-year survival rates, likely linked to pandemic-related disruptions in screenings and timely treatment, researchers say.
- A new study found people diagnosed with cancer in 2020 and 2021 had worse short-term survival than those diagnosed between 2015 and 2019.
- The researchers were unable to definitively determine what drove the worse survival, but pandemic disruptions to healthcare were likely a key contributor.
- COVID-19 forced many people to postpone cancer screenings as the coronavirus overwhelmed doctors and hospitals, especially in 2020.
36 Articles
36 Articles
During the early years of the COVID-19 pandemic, experts feared that disruptions to cancer diagnosis and treatment would cost lives. A new study suggests they were right.
Associated Press News
Pandemic disruptions to health care worsened cancer survival, study suggests
A new study reveals that cancer patients diagnosed during the early COVID-19 pandemic had worse short-term survival rates than a similar group before the pandemic.
Patients diagnosed with cancer between 2020 and 2021 had less short-term survival than those diagnosed between 2015 and 2019.
Patient Survival Rates Following Cancer Diagnosis Amid the COVID-19
A recent cohort study published in JAMA Oncology reveals disturbing evidence that the COVID-19 pandemic has exerted profound and detrimental effects on short-term cancer survival rates. Researchers have found that individuals diagnosed with cancer during the tumultuous years of 2020 and 2021 experienced significantly worse outcomes compared to those diagnosed in the preceding years from […]
Coverage Details
Bias Distribution
- 42% of the sources lean Left, 42% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
